Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, Sold Out, 2024 Q2

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Sold out

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q2 2024: Stock MICROSTRATEGY INC; Country of operation —; Class NOTE 0.750%12/1; Principal before $36,000,000.
  • Q2 2024: Stock CYTOKINETICS INC; Country of operation —; Class NOTE 3.500% 7/0; Principal before $44,350,000.
  • Q2 2024: Stock HARMONIC INC; Country of operation —; Class DBCV 2.000% 9/0; Principal before $40,000,000.
  • Q2 2024: Stock SAREPTA THERAPEUTICS INC; Country of operation —; Class NOTE 1.250% 9/1; Principal before $32,940,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2024MICROSTRATEGY INC
CUSIP 594972AC5
—NOTE 0.750%12/1$36,000,000$0-36,000,000$154,453,993$0-$154,453,9932024-08-14
Q2 2024CYTOKINETICS INC
CUSIP 23282WAC4
—NOTE 3.500% 7/0$44,350,000$0-44,350,000$70,395,403$0-$70,395,4032024-08-14
Q2 2024HARMONIC INC
CUSIP 413160AD4
—DBCV 2.000% 9/0$40,000,000$0-40,000,000$62,700,000$0-$62,700,0002024-08-14
Q2 2024SAREPTA THERAPEUTICS INC
CUSIP 803607AD2
—NOTE 1.250% 9/1$32,940,000$0-32,940,000$38,558,342$0-$38,558,3422024-08-14
Q2 2024MARCUS CORP DEL
CUSIP 566330AB2
—NOTE 5.000% 9/1$21,401,000$0-21,401,000$30,549,213$0-$30,549,2132024-08-14
Q2 2024BLOOM ENERGY CORP
CUSIP 093712AH0
—NOTE 2.500% 8/1$27,500,000$0-27,500,000$28,926,542$0-$28,926,5422024-08-14
Q2 2024INNOVIVA INC
CUSIP 45781MAB7
—NOTE 2.500% 8/1$20,299,000$0-20,299,000$21,789,877$0-$21,789,8772024-08-14
Q2 2024FIRST MAJESTIC SILVER CORP
CUSIP 32076VAD5
—NOTE 0.375% 1/1$21,120,000$0-21,120,000$16,789,005$0-$16,789,0052024-08-14
Q2 2024TYLER TEX INDPT SCH DIST
CUSIP 902252AB1
—NOTE 0.250% 3/1$14,000,000$0-14,000,000$14,116,352$0-$14,116,3522024-08-14
Q2 2024CNX RES CORP
CUSIP 12653CAG3
—NOTE 2.250% 5/0$7,085,000$0-7,085,000$13,418,976$0-$13,418,9762024-08-14
Q2 2024GLAUKOS CORP
CUSIP 377322AB8
—NOTE 2.750% 6/1$7,000,000$0-7,000,000$12,543,445$0-$12,543,4452024-08-14
Q2 2024SNAP INC
CUSIP 83304AAB2
—NOTE 0.750% 8/0$12,500,000$0-12,500,000$12,019,704$0-$12,019,7042024-08-14
Q2 2024CENTURY ALUM CO
CUSIP 156431AQ1
—NOTE 2.750% 5/0$11,394,000$0-11,394,000$11,640,650$0-$11,640,6502024-08-14
Q2 2024HALOZYME THERAPEUTICS INC
CUSIP 40637HAD1
United StatesNOTE 0.250% 3/0$11,425,000$0-11,425,000$10,143,560$0-$10,143,5602024-08-14
Q2 2024LYV
LIVE NATION ENTERTAINMENT IN
United StatesNOTE 3.125% 1/1$5,000,000$0-5,000,000$6,012,507$0-$6,012,5072024-08-14
Q2 2024GUESS INC
CUSIP 401617AD7
—NOTE 2.000% 4/1$2,448,000$0-2,448,000$2,738,935$0-$2,738,9352024-08-14
Q2 2024BIOMARIN PHARMACEUTICAL INC
CUSIP 09061GAH4
—NOTE 0.599% 8/0$2,000,000$0-2,000,000$1,968,479$0-$1,968,4792024-08-14
Q2 2024NCL CORP LTD
CUSIP 62886HBD2
—NOTE 1.125% 2/1$2,000,000$0-2,000,000$1,890,301$0-$1,890,3012024-08-14
Q2 2024WINNEBAGO INDS INC
CUSIP 974637AB6
—NOTE 1.500% 4/0$1,365,000$0-1,365,000$1,694,772$0-$1,694,7722024-08-14
Q2 2024INSEEGO CORP
CUSIP 45782BAD6
—NOTE 3.250% 5/0$4,000,000$0-4,000,000$1,543,485$0-$1,543,4852024-08-14
Q2 2024OMNICELL COM
CUSIP 68213NAD1
—NOTE 0.250% 9/1$1,500,000$0-1,500,000$1,409,378$0-$1,409,3782024-08-14
Q2 2024SUNNOVA ENERGY INTL INC.
CUSIP 86745KAF1
—NOTE 0.250%12/0$2,500,000$0-2,500,000$1,293,097$0-$1,293,0972024-08-14
Q2 2024BRIDGEBIO PHARMA INC
CUSIP 10806XAB8
United StatesNOTE 2.500% 3/1$24,000$0-24,000$25,825$0-$25,8252024-08-14